Login / Signup

Exploring triheptanoin as treatment for short chain enoyl CoA hydratase deficiency.

Kristin M EngelstadRachel SalazarDorcas KoenigsbergerErin StackowtizSusan BrodlieMelanie BrandaburDarryl C De Vivo
Published in: Annals of clinical and translational neurology (2021)
We explored the benefits of triheptanoin as a treatment for Short Chain Enoyl Co-A Hydratase (SCEH) deficiency. One child with early onset, severe SCEH Deficiency was treated with triheptanoin, an odd chain oil with anapleurotic properties, for 37 months. Blood and urine chemistry safety measures, motor skills assessment, physical exam, and neurological assessment were monitored over a 27 month period. Modest sustained gains in motor skills, attention, muscle bulk, and strength were observed without any significant adverse effects. Triheptanoin appears to be a promising effective treatment for SCEH Deficiency.
Keyphrases
  • early onset
  • replacement therapy
  • mental health
  • late onset
  • physical activity
  • working memory
  • brain injury
  • newly diagnosed
  • cerebral ischemia
  • clinical evaluation